PF-Atlas › Clinical Trials › NCT00004705

Study of Uridine Triphosphate as an Aerosol Spray for Cystic Fibrosis

amiloride · Not specified

Registry ID

NCT00004705

Phase

Not specified

Status

Completed

Drug / intervention

amiloride

Sponsor

FDA Office of Orphan Products Development

Start

1996-09

About this trial

OBJECTIVES: I. Determine the stability of uridine triphosphate (UTP) and examine the metabolism of exogenous nucleotides on airway epithelial surfaces in patients with cystic fibrosis. II. Determine the acute safety and efficacy of aerosolized UTP in children with cystic fibrosis.

View NCT00004705 on ClinicalTrials.gov →

Explore related

All amiloride trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00004705 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.